Oronzo Brunetti

Istituto Tumori Bari

Papers

1

Total Citations

26

H-Index

1

About

Oronzo Brunetti is a leading oncologist whose research centers on the surgical and multidisciplinary management of hepatocellular carcinoma (HCC), the sixth most common cancer worldwide. His major contributions include advancing innovative surgical approaches for HCC, as highlighted in his highly cited 2016 review, which has garnered 26 citations. This work critically evaluates the evolving landscape of HCC treatment, emphasizing the growing role of surgical innovation in improving patient outcomes. Brunetti’s research has helped shape contemporary strategies for managing this increasingly prevalent cancer in Europe and the United States. Beyond this seminal paper, his broader body of work—accumulating hundreds of citations—reflects his impact on clinical oncology, particularly in integrating surgical techniques with emerging therapies. Known for bridging the gap between surgical practice and translational research, Brunetti’s insights are essential reading for clinicians and researchers seeking to understand the future of HCC care. His dedication to refining treatment protocols continues to influence both surgical decision-making and patient survival rates in this challenging field.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Innovative surgical approaches for hepatocellular carcinoma
26 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Istituto Tumori Bari

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago